Dianthus Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 05/12/2025 | 4.48 M | $81.31 M | 0.98% | 13.09% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 2.87 M | $52.00 M | 53.60% | 8.37% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 05/15/2025 | 2.70 M | $48.99 B | 0.00% | 7.89% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 2.69 M | $48.79 M | 0.00% | 7.86% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.36 M | $42.77 M | 100.00% | 6.89% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 2.34 M | $42.48 M | 10.97% | 6.84% |
VR ADVISER, LLC | 05/15/2025 | 1.74 M | $31.64 M | 0.00% | 5.10% |
AVIDITY PARTNERS MANAGEMENT LP | 05/15/2025 | 1.72 M | $31.22 B | -40.10% | 5.03% |
VESTAL POINT CAPITAL, LP | 05/15/2025 | 1.70 M | $30.84 M | 58.15% | 4.97% |
BLACKROCK, INC. | 05/02/2025 | 1.62 M | $29.31 M | -2.13% | 4.72% |
TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 1.50 M | $27.24 M | 0.00% | 4.39% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.49 M | $26.97 M | 668.05% | 4.34% |
VANGUARD GROUP INC | 05/09/2025 | 1.11 M | $20.11 M | -13.00% | 3.24% |
5AM VENTURE MANAGEMENT, LLC | 05/15/2025 | 1.03 M | $18.64 B | 0.00% | 3.00% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 1.03 M | $18.60 M | -11.57% | 3.00% |
05/15/2025 | 763.47 K | $13.85 M | 0.00% | 2.23% | |
STATE STREET CORP | 05/15/2025 | 759.68 K | $13.78 M | -7.23% | 2.22% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 683.62 K | $13.70 M | -37.03% | 2.00% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 517.02 K | $9.38 M | 6.32% | 1.51% |
CITADEL ADVISORS LLC | 05/15/2025 | 470.88 K | $8.54 M | 11.57% | 1.38% |
BRAIDWELL LP | 05/15/2025 | 375.36 K | $6.81 M | -68.89% | 1.10% |
WOODLINE PARTNERS LP | 05/15/2025 | 300.50 K | $5.45 M | 0.00% | 0.88% |
GREAT POINT PARTNERS LLC | 05/15/2025 | 275.00 K | $4.99 M | 0.00% | 0.80% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 264.69 K | $4.80 M | 0.00% | 0.77% |
CANDRIAM S.C.A. | 05/14/2025 | 248.61 K | $4.51 M | 100.00% | 0.73% |
NORTHERN TRUST CORP | 05/13/2025 | 235.53 K | $4.27 M | -4.07% | 0.69% |
ALPHABET INC. | 05/02/2025 | 208.70 K | $3.79 M | 0.00% | 0.61% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 190.33 K | $3.45 M | 100.00% | 0.56% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 189.00 K | $3.43 M | 5.00% | 0.55% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 168.10 K | $3.05 M | 0.65% | 0.49% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2025 | 126.63 K | $2.30 M | 11.08% | 0.37% |
SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 117.00 K | $2.12 M | 100.00% | 0.34% |
WALLEYE CAPITAL LLC | 05/14/2025 | 106.93 K | $1.94 M | 29.00% | 0.31% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 93.29 K | $1.69 M | 19.33% | 0.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 81.60 K | $1.48 M | 100.00% | 0.24% |
ALLY BRIDGE GROUP (NY) LLC | 05/15/2025 | 80.58 K | $1.46 M | -24.29% | 0.24% |
MORGAN STANLEY | 05/15/2025 | 79.17 K | $1.44 M | -31.78% | 0.23% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 75.00 K | $1.36 M | 100.00% | 0.22% |
MOODY ALDRICH PARTNERS LLC | 04/29/2025 | 74.37 K | $1.35 M | 100.00% | 0.22% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 73.64 K | $1.34 M | 1.03% | 0.22% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 73.43 K | $1.33 M | -64.71% | 0.21% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 67.98 K | $1.23 M | 12.67% | 0.20% |
05/12/2025 | 64.38 K | $1.17 M | 100.00% | 0.19% | |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 47.82 K | $867.40 K | 8.68% | 0.14% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 47.38 K | $859.44 K | 186.76% | 0.14% |
PNC FINANCIAL SERVICES GROUP, INC. | 05/09/2025 | 37.10 K | $672.99 K | 0.00% | 0.11% |
RHUMBLINE ADVISERS | 04/08/2025 | 35.05 K | $635.71 K | -2.47% | 0.10% |
CITIGROUP INC | 05/12/2025 | 34.82 K | $631.64 K | 14.01% | 0.10% |
HIGHVISTA STRATEGIES LLC | 05/15/2025 | 31.39 K | $569.36 K | 0.00% | 0.09% |
BARCLAYS PLC | 05/15/2025 | 31.14 K | $565.00 K | -27.18% | 0.09% |
Dianthus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 103 institutional investors and hedge funds held shares of Dianthus Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 4.48 M
RA CAPITAL MANAGEMENT, L.P.: 2.87 M
Fairmount Funds Management LLC: 2.7 M
Bain Capital Life Sciences Investors, LLC: 2.69 M
Deep Track Capital, LP: 2.36 M
Octagon Capital Advisors LP: 2.34 M
110.16% of Dianthus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 38.50 M shares in the last 24 months. This purchase volume represents approximately $709.43 M in transactions.